Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Higher Part D Premiums Whet Waxman’s Appetite For HHS Price Negotiation

Executive Summary

Increasing Part D premiums have caught the eye of Rep. Henry Waxman, who sees them as further evidence that HHS would do a better job of negotiating drug prices for Part D than the private sector

You may also be interested in...



House Energy & Commerce Democratic Leadership Seeks Hearing On Part D Waste And Fraud

Request follows HHS Office of Inspector General report that shows plans underestimated rebates in 2008, which led to higher beneficiary premiums.

CMS Aims To Reduce 2010 Part D Churn With New Benchmark Formula

CMS has found a way to reduce the number of drug plan reassignments that would be needed for low-income Medicare Part D beneficiaries in 2010 by adjusting its calculation of the low-income premium benchmark

CMS Aims To Reduce 2010 Part D Churn With New Benchmark Formula

CMS has found a way to reduce the number of drug plan reassignments that would be needed for low-income Medicare Part D beneficiaries in 2010 by adjusting its calculation of the low-income premium benchmark

Related Content

UsernamePublicRestriction

Register

PS050238

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel